Loading
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Latest filing published 05 Sept 2024 for Nuvation Bio Inc.. Read the official filing
Filing timeline
BuySaleXiangmin Cui
Insider track record
Disclosed buys
4
Disclosed sells
0
Signal history
Closed purchases
Market purchases
4
Positive at T+90
0%
Median T+90
-16.2%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -36.5%Entry US$3.04 · Close at T+365 US$1.93
- -34.1%Entry US$2.99 · Close at T+365 US$1.97
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Xiangmin Cui: trading record in brief
This profile gathers the share dealings of Xiangmin Cui across 3 companies, led by Alpine Immune Sciences, Inc., Nuvation Bio Inc. and Cue Health Inc. Between 17 September 2021 and 4 September 2024, the trades on record add up to 11 filings.
Every open-market trade on record is a purchase: 4 purchases worth €17.7M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 4 share grants. Since January 2024: 2 purchases and no sales on the market.
A typical purchase (the median) is worth €2.6M. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 5 September 2024: a transaction, in Nuvation Bio Inc. The last insider purchase was made public on 26 June 2024, 844 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Xiangmin Cui
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
967,100 sharesClass A Common StockSEC:0001415889-24-022899:0
277,895 shares@ US$2.9775.9% of flowClass A Common StockSEC:0001415889-24-018231:0
Canonical exit: 23 Sept 2024 (T+90)
87,715 shares@ US$2.9924.1% of flowClass A Common StockSEC:0001415889-24-018162:0
Canonical exit: 18 Sept 2024 (T+90)
6,582,380 sharesCommon StockSEC:0001626199-24-000095:0
314,106 sharesClass A Common StockSEC:0001415889-24-010738:0
1,234,636 shares@ US$12.7442.8% of flowCommon StockSEC:0001209191-24-002014:0
▲
Same trade as the filing by Decheng Capital Global Healthcare Fund (Master), LP, counted once · View ↗
375,000 shares@ US$12.5013.0% of flowCommon StockSEC:0001209191-23-055208:0
Canonical exit: 7 Feb 2024 (T+90)
639,456 shares@ US$7.3514.1% of flowCommon StockSEC:0001209191-22-051372:0
1,360,544 shares@ US$7.3530.1% of flowCommon StockSEC:0001209191-22-051372:1
8,192,468 sharesCommon StockSEC:0001140361-21-033147:0
1,542,553 shares@ US$9.40100.0% of flowCommon StockSEC:0001626199-21-000112:0
Canonical exit: 16 Dec 2021 (T+90)
11 of 10 declarations
